Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 AUD | 0.00% | 0.00% | +12.50% |
Apr. 10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
Feb. 23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.33M 2.14M | Sales 2023 | 2.85M 1.83M | Capitalization | 20.57M 13.2M |
---|---|---|---|---|---|
Net income 2022 | -6M -3.85M | Net income 2023 | -7M -4.49M | EV / Sales 2022 | 9.39 x |
Net cash position 2022 | 9.82M 6.3M | Net cash position 2023 | 4.05M 2.6M | EV / Sales 2023 | 5.8 x |
P/E ratio 2022 |
-5.78
x | P/E ratio 2023 |
-2.91
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.29% |
6 months | +12.50% | ||
Current year | +12.50% |
Managers | Title | Age | Since |
---|---|---|---|
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Chief Tech/Sci/R&D Officer | - | 12-05-31 | |
Rebecca Tunstall
PRN | Corporate Officer/Principal | - | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pamela Klein
BRD | Director/Board Member | 63 | 19-09-30 |
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Michael Stork
BRD | Director/Board Member | - | 07-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.009 | 0.00% | 100,000 |
24-04-18 | 0.009 | 0.00% | 100,000 |
24-04-17 | 0.009 | -10.00% | 1,471,063 |
24-04-16 | 0.01 | 0.00% | 1,500,000 |
24-04-15 | 0.01 | +11.11% | 174,383 |
Delayed Quote Australian S.E., April 18, 2024 at 11:21 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.50% | 11.91M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- PAB Stock